Cargando…

Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease

Parkinson’s disease (PD) is a chronic, progressive, and the second most common form of neurodegenerative disorders. In order to explore novel agents for the treatment of PD, in the current study, we have evaluated the neuroprotective efficacy of ferulic acid (FA) using rotenone (ROT)-induced rat mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Ojha, Shreesh, Javed, Hayate, Azimullah, Sheikh, Abul Khair, Salema B, Haque, M Emdadul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603721/
https://www.ncbi.nlm.nih.gov/pubmed/26504373
http://dx.doi.org/10.2147/DDDT.S90616
_version_ 1782394944361594880
author Ojha, Shreesh
Javed, Hayate
Azimullah, Sheikh
Abul Khair, Salema B
Haque, M Emdadul
author_facet Ojha, Shreesh
Javed, Hayate
Azimullah, Sheikh
Abul Khair, Salema B
Haque, M Emdadul
author_sort Ojha, Shreesh
collection PubMed
description Parkinson’s disease (PD) is a chronic, progressive, and the second most common form of neurodegenerative disorders. In order to explore novel agents for the treatment of PD, in the current study, we have evaluated the neuroprotective efficacy of ferulic acid (FA) using rotenone (ROT)-induced rat model of PD. ROT was administered 2.5 mg/kg body weight to male Wistar rats for 4 weeks to induce the PD. Since PD is progressive and chronic in nature, the paradigm for evaluating FA was based on chronic administration for 4 weeks at the dose of 50 mg/kg, 30 minutes prior to ROT administration. ROT administration caused significant reduction in endogenous antioxidants such as superoxide dismutase, catalase, and glutathione. ROT challenge-induced lipid peroxidation evidenced by increased malondialdehyde following perturbation of antioxidant defense. Apart from oxidative stress, ROT also activated proinflammatory cytokines and enhanced inflammatory mediators such as cyclooxygenase-2 and inducible nitric oxide synthase. The immunofluorescence analysis revealed a significant increase in the number of activated microglia and astrocytes accompanied by a significant loss of dopamine (DA) neurons in the substantia nigra pars compacta area upon ROT injection. However, treatment with FA rescued DA neurons in substantia nigra pars compacta area and nerve terminals in the striatum from the ROT insult. FA treatment also restored antioxidant enzymes, prevented depletion of glutathione, and inhibited lipid peroxidation. Following treatment with FA, the inflammatory mediators such as cyclooxygenase-2 and inducible nitric oxide synthase and proinflammatory cytokines were also reduced. Further, the results were supported by a remarkable reduction of Iba-1 and GFAP hyperactivity clearly suggests attenuation of microglial and astrocytic activation. Results of our study suggest that FA has promising neuroprotective effect against degenerative changes in PD, and the protective effects are mediated through its antioxidant and anti-inflammatory properties.
format Online
Article
Text
id pubmed-4603721
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-46037212015-10-26 Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease Ojha, Shreesh Javed, Hayate Azimullah, Sheikh Abul Khair, Salema B Haque, M Emdadul Drug Des Devel Ther Original Research Parkinson’s disease (PD) is a chronic, progressive, and the second most common form of neurodegenerative disorders. In order to explore novel agents for the treatment of PD, in the current study, we have evaluated the neuroprotective efficacy of ferulic acid (FA) using rotenone (ROT)-induced rat model of PD. ROT was administered 2.5 mg/kg body weight to male Wistar rats for 4 weeks to induce the PD. Since PD is progressive and chronic in nature, the paradigm for evaluating FA was based on chronic administration for 4 weeks at the dose of 50 mg/kg, 30 minutes prior to ROT administration. ROT administration caused significant reduction in endogenous antioxidants such as superoxide dismutase, catalase, and glutathione. ROT challenge-induced lipid peroxidation evidenced by increased malondialdehyde following perturbation of antioxidant defense. Apart from oxidative stress, ROT also activated proinflammatory cytokines and enhanced inflammatory mediators such as cyclooxygenase-2 and inducible nitric oxide synthase. The immunofluorescence analysis revealed a significant increase in the number of activated microglia and astrocytes accompanied by a significant loss of dopamine (DA) neurons in the substantia nigra pars compacta area upon ROT injection. However, treatment with FA rescued DA neurons in substantia nigra pars compacta area and nerve terminals in the striatum from the ROT insult. FA treatment also restored antioxidant enzymes, prevented depletion of glutathione, and inhibited lipid peroxidation. Following treatment with FA, the inflammatory mediators such as cyclooxygenase-2 and inducible nitric oxide synthase and proinflammatory cytokines were also reduced. Further, the results were supported by a remarkable reduction of Iba-1 and GFAP hyperactivity clearly suggests attenuation of microglial and astrocytic activation. Results of our study suggest that FA has promising neuroprotective effect against degenerative changes in PD, and the protective effects are mediated through its antioxidant and anti-inflammatory properties. Dove Medical Press 2015-10-07 /pmc/articles/PMC4603721/ /pubmed/26504373 http://dx.doi.org/10.2147/DDDT.S90616 Text en © 2015 Ojha et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Ojha, Shreesh
Javed, Hayate
Azimullah, Sheikh
Abul Khair, Salema B
Haque, M Emdadul
Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
title Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
title_full Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
title_fullStr Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
title_full_unstemmed Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
title_short Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
title_sort neuroprotective potential of ferulic acid in the rotenone model of parkinson’s disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603721/
https://www.ncbi.nlm.nih.gov/pubmed/26504373
http://dx.doi.org/10.2147/DDDT.S90616
work_keys_str_mv AT ojhashreesh neuroprotectivepotentialofferulicacidintherotenonemodelofparkinsonsdisease
AT javedhayate neuroprotectivepotentialofferulicacidintherotenonemodelofparkinsonsdisease
AT azimullahsheikh neuroprotectivepotentialofferulicacidintherotenonemodelofparkinsonsdisease
AT abulkhairsalemab neuroprotectivepotentialofferulicacidintherotenonemodelofparkinsonsdisease
AT haquememdadul neuroprotectivepotentialofferulicacidintherotenonemodelofparkinsonsdisease